0001209191-23-058948.txt : 20231218
0001209191-23-058948.hdr.sgml : 20231218
20231218160932
ACCESSION NUMBER: 0001209191-23-058948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kessler Marla L
CENTRAL INDEX KEY: 0001772124
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 231493796
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-14
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001772124
Kessler Marla L
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300
BOSTON
MA
02110
1
0
0
0
1
Class A Common Stock
2023-12-14
4
S
0
9926
11.19
D
96572
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 7, 2023, to satisfy tax obligations in connection with the vesting of 21,571 restricted stock awards on June 19, 2023.
/s/ Brian Tessler, Attorney-in-Fact
2023-12-18